GE MEDICAL SYSTEMS INFORMATION TECHNOLOGIES, INC. - BAA2023-1 RESEARCH AREA 004: DEVELOPMENT OF IN VITRO DIAGNOSTICS FOR BIODEFENSE, ANTIMICROBIAL RESISTANT INFECTIONS (AMR), AND EMERGING INFECTIOUS DISEASES

PIID: 75N93024C00051Solicitation ID: HHS-NIH-NIAID-BAA2023-1

Signed Date: Mar 4, 2026Effective Date: Sep 18, 2024End Date: Closes in 62 days

Key Details

Dollars Obligated

$4.2M

Base & All Options

Awarding Agency

Department of Health and Human Services

Awarding Sub-Agency

National Institutes of Health

NAICS Code

541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)

Product Service Code

AN12 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH

Extent Competed

FULL AND OPEN COMPETITION

Number of Offers

Place of Performance

SCHENECTADY, NY, 123091027, CD-NY-20

Description

BAA2023-1 RESEARCH AREA 004: DEVELOPMENT OF IN VITRO DIAGNOSTICS FOR BIODEFENSE, ANTIMICROBIAL RESISTANT INFECTIONS (AMR), AND EMERGING INFECTIOUS DISEASES

Contractor Information

Contractor: GE MEDICAL SYSTEMS INFORMATION TECHNOLOGIES, INC.

UEI: G2JTZ3UQV9M3

CAGE Code: 9G8T4

Location: NISKAYUNA, NY

Similar Awards

NCI OPERATIONAL TASK ORDER, FY26-FY27

LEIDOS BIOMEDICAL RESEARCH INC

$327.1M

MD NET

LEIDOS BIOMEDICAL RESEARCH INC

$163.5M

ADVANCE UNIVERSAL INFLUENZA VACCINE - FLU MOSAIC VERSION 2 (FLUMOSV2)

LEIDOS BIOMEDICAL RESEARCH INC

$141.7M

AWARD OF THE BASE TO ST. JUDE FOR CEIRR CONTRACT 75N93021C00016. THIS CONTRACT WILL SUPPORT NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR).

ST JUDE CHILDREN'S RESEARCH HOSPITAL INC

$103.3M

DOMESTIC INDUSTRIAL BASE EXPANSION OF KEY CHEMICALS FOR ACRYLONITRILE BUTADIENE RUBBER (NBR)

ASCEND PERFORMANCE MATERIALS TEXAS INC

$87.7M

View Full Record on USASpending.gov